UK alert prompts new scrutiny of MOM hips

By Terry Stanton

In April, the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) issued a Medical Device Alert on metal-on-metal (MOM) hip devices. The alert does not impose any restrictions on MOM device use, but notes reports of revisions of MOM total hip replacement or resurfacing procedures involving soft-tissue reactions or pseudotumors.

Although patients “are thought to be at a low risk of developing serious problems,” the alert states that progressive reactions to wear debris of MOM articulations, which can cause soft-tissue necrosis and adversely affect the results of revision surgery, may develop in a small number.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!